Pharmaceutical Regulations
2 articles on Pharmaceutical Regulations, written by Shotlee and medically reviewed for clinical accuracy.
FDA requests removal of suicide warning labels from GLP-1 weight-loss medications
The Food and Drug Administration announced on Tuesday its desire to remove suicide warning labels from GLP-1 weight-loss medications. A comprehensive review of 91 trials revealed no heightened risk of suicidal thoughts or behaviors among users compared to placebo groups. This change aligns the labels with those of diabetes equivalents from the same manufacturers.
2 min read
Querying 'weight' might display Ozempic in search outcomes. This is a pharmaceutical promotion gap
When individuals search for 'weight loss,' Ozempic often appears prominently despite lacking FDA approval for that purpose. This occurs through paid search advertisements that bypass traditional ad regulations. Experts urge consumers to seek independent sources for accurate health information.
3 min read